Ipratropium Bromide Solution
Product Images NDC 0487-9801

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Ipratropium Bromide (NDC 0487-9801). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nephron Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

97e130d5-figure-01 (97e130d5 Figure 01)

Chemical structure of Ipratropium Bromide monohydrate showing its molecular formula C20H30BrNO3·H2O and molecular weight 430.4. The diagram includes the structural layout of the compound's atoms and bonds as part of the medication’s chemical identification.*

FDA Label Image

97e130d5-figure-02 (97e130d5 Figure 02)

An instructional line drawing showing two hands opening a single-dose vial or ampule, likely for respiratory inhalation solution use. One hand holds the vial steady while the other hand snaps off the top.*

FDA Label Image

97e130d5-figure-03 (97e130d5 Figure 03)

An instructional line drawing depicting a hand holding a vial or ampule and snapping off the top, typically a preparatory step for using a respiratory inhalation solution such as Ipratropium Bromide. The image focuses on demonstrating proper vial opening technique.*

FDA Label Image

97e130d5-figure-04 (97e130d5 Figure 04)

An instructional diagram depicting a person using a respiratory inhalation device. It shows the mouthpiece of the inhaler positioned at the mouth, illustrating the correct method of inhalation for the solution dosage form.*

FDA Label Image

97e130d5-figure-05 (97e130d5 Figure 05)

Label for Ipratropium Bromide Inhalation Solution 0.02% (0.5 mg/2.5 mL) by Nephron Pharmaceuticals Corporation. The label indicates sterile, prescription-only solution in 5 unit-dose vials of 2.5 mL each, for oral inhalation use only. Storage instructions and pharmacist dispensing notes are included. Barcode and manufacturer contact details are visible.*

FDA Label Image

97e130d5-figure-06 (97e130d5 Figure 06)

Packaging label for Ipratropium Bromide Inhalation Solution 0.5 mg/2.5 mL, a respiratory inhalation solution by Nephron Pharmaceuticals Corporation. The label indicates it is for prescription use only and contains 25 sterile unit-dose vials of 2.5 mL each. The label includes an NDC code 0487-9801-25 and storage instructions.*

FDA Label Image

97e130d5-figure-07 (97e130d5 Figure 07)

Packaging label for Ipratropium Bromide Inhalation Solution 0.5 mg/2.5 mL vial from Nephron Pharmaceuticals Corporation. The label indicates the product strength as 0.02%, includes the NDC 0487-9801-30, and states the package contains 30 sterile unit-dose vials for respiratory inhalation. The label also notes the product is prescription only (Rx Only).*

FDA Label Image

97e130d5-figure-08 (97e130d5 Figure 08)

Packaging label for Ipratropium Bromide Inhalation Solution 0.02%, 0.5 mg/2.5 mL vial by Nephron Pharmaceuticals Corporation. The box contains 60 sterile unit-dose vials for oral inhalation only, not for injection. The label features blue and green geometric patterns, NDC 0487-9801-60, and states prescription use only.*

FDA Label Image

97e130d5-figure-09 (97e130d5 Figure 09)

Ipratropium Bromide Inhalation Solution 0.5 mg/2.5 mL vial label showing drug strength as 0.02%. The label states it is for oral inhalation only, not for injection, and provides storage instructions between 15° and 30°C (59° to 86°F), with protection from light. It is a sterile solution in a unit-dose vial, manufactured by Nephron Pharmaceuticals Corporation. The label includes a barcode and contact information for customer service.*

FDA Label Image

97e130d5-figure-10 (97e130d5 Figure 10)

The image shows the carton packaging layout for Ipratropium Bromide Inhalation Solution 0.02%, 0.5 mg/2.5 mL, by Nephron Pharmaceuticals Corporation. The label includes the product name, strength, dosage form (solution for respiratory inhalation), usage instructions for oral inhalation only, and the package size of 30 sterile unit-dose vials in a foil pouch. The NDC 0487-9801 is also displayed on the carton.*

FDA Label Image

97e130d5-figure-11 (97e130d5 Figure 11)

Flattened packaging label for Ipratropium Bromide inhalation solution, 0.5 mg/2.5 mL, by Nephron Pharmaceuticals Corporation. The label includes text information and a structural diagram, suitable for respiratory inhalation use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.